Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 28, 2011 | March 02, 2011 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 28, 2011 · Filed March 02, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 109,429 |
Ending reported balance
After 2011-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2011-02-28 · Tax withholding · Disposed 8,526 · Balance 110,993 Row 2 · 2011-02-28 · Sale · Disposed 100 · Balance 110,893 Row 3 · 2011-02-28 · Sale · Disposed 600 · Balance 110,293 Row 4 · 2011-02-28 · Sale · Disposed 864 · Balance 109,429 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 14,342 |
Reported balance
Holding disclosure · report date 2011-02-28 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 14,342 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2011.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2008 Filed Jul 11, 2008 22:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 8,451 | $45.45 | $384,087.81 |
DisclosureSEC source: 0001104659-08-045349 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2008 Filed Apr 18, 2008 15:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,741 | $51.91 | $90,375.31 |
DisclosureSEC source: 0001104659-08-025240 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,541 Read SEC document |
| March 03, 2008 Filed Mar 5, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,003 | $0.00 Strike: $53.55 | $0.00 |
DisclosureSEC source: 0001104659-08-015564 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003 Underlying: common shares · 2,003 shares Expires 2009-02-11 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 03, 2008 Filed Mar 5, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,330 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-08-015564 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 Underlying: common shares · 2,330 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| March 03, 2008 Filed Mar 5, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,003 | $53.55 | $107,260.65 |
DisclosureSEC source: 0001104659-08-015564 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,282 Read SEC document |
| March 03, 2008 Filed Mar 5, 2008 23:26 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,330 | $42.50 | $99,019.87 |
DisclosureSEC source: 0001104659-08-015564 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2008 Filed Mar 5, 2008 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 294 | $53.49 | $15,726.94 |
DisclosureSEC source: 0001104659-08-015217 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,955 Read SEC document |
| February 29, 2008 Filed Mar 5, 2008 01:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,027 | $54.22 | $55,683.94 |
DisclosureSEC source: 0001104659-08-015217 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,249 Read SEC document |
| February 19, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 554 | $56.05 | $31,052.25 |
DisclosureSEC source: 0001104659-08-011840 · a4.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,276 Read SEC document |
| February 18, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 479 | $55.55 | $26,608.45 |
DisclosureSEC source: 0001104659-08-011840 · a4.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,830 Read SEC document |
| February 17, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,459 | $55.55 | $81,047.45 |
DisclosureSEC source: 0001104659-08-011840 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,309 Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 78,700 | $0.00 Strike: $55.56 | $0.00 |
DisclosureSEC source: 0001104659-08-011840 · a4.xml · derivative · entry 6 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,700 Underlying: common shares · 78,700 shares Expires 2018-02-14 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,234 on 02/15/2009, 26,233 on 02/15/2010, and 26,233 on 02/15/2011. Read SEC document |
| February 15, 2008 Filed Feb 20, 2008 23:31 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 19,700 | $55.56 | $1,094,532.00 |
DisclosureSEC source: 0001104659-08-011840 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,768 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 912 | $0.00 Strike: $46.77 | $0.00 |
DisclosureSEC source: 0001104659-08-009505 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 912 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 912 | $56.77 | $51,770.59 |
DisclosureSEC source: 0001104659-08-009505 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,068 Read SEC document |
| February 08, 2008 Filed Feb 12, 2008 23:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 912 | $46.77 | $42,654.24 |
DisclosureSEC source: 0001104659-08-009505 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 6,366 | $0.00 Strike: $58.26 | $0.00 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · derivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6.366 Underlying: common shares · 6.366 shares Expires 2009-02-11 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 7,552 | $0.00 Strike: $42.50 | $0.00 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,683 Underlying: common shares · 7,552 shares Expires 2009-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,366 | $58.26 | $370,883.16 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,068 Read SEC document |
| December 24, 2007 Filed Dec 26, 2007 19:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 7,552 | $42.50 | $320,943.39 |
DisclosureSEC source: 0001104659-07-090848 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2007 Filed Sep 5, 2007 21:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,225 | $51.91 | $63,589.75 |
DisclosureSEC source: 0001104659-07-067131 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,882 Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,909 | $0.00 Strike: $54.68 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 12 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,909 Underlying: common shares · 1,909 shares Expires 2013-02-13 F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,640 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 11 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,193 Underlying: common shares · 2,640 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,762 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 10 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,762 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,921 | $0.00 Strike: $43.70 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 9 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 4,921 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,778 | $0.00 Strike: $48.37 | $0.00 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · derivative · entry 8 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,778 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 9,192 | $54.25 | $498,675.19 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 6 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,107 Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,909 | $54.68 | $104,384.12 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 5 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,299 Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,640 | $33.23 | $87,730.90 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,762 | $34.72 | $61,181.40 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 3 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,921 | $43.70 | $215,051.64 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2007 Filed Jun 22, 2007 19:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,778 | $48.37 | $85,996.35 |
DisclosureSEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 16, 2007 Filed Apr 18, 2007 16:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 47,300 | $0.00 Strike: $58.86 | $0.00 |
DisclosureSEC source: 0001104659-07-029050 · a4.xml · derivative · entry 4 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,300 Underlying: common shares · 47,300 shares Expires 2017-04-15 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 15,767 on 4/16/2008, 15,767 on 4/16/09, and 15,766 on 4/16/10. Read SEC document |
| April 16, 2007 Filed Apr 18, 2007 16:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 5,000 | $58.86 | $294,300.00 |
DisclosureSEC source: 0001104659-07-029050 · a4.xml · nonDerivative · entry 2 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,107 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| April 16, 2007 Filed Apr 18, 2007 16:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 11,600 | $58.86 | $682,776.00 |
DisclosureSEC source: 0001104659-07-029050 · a4.xml · nonDerivative · entry 1 Patton Donald V JR · CIK 0001396490 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,107 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.